JNK Suppression of Chemotherapeutic Agents-Induced ROS Confers Chemoresistance on Pancreatic Cancer Stem Cells

Oncotarget - United States
doi 10.18632/oncotarget.2693
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Exosomes Confer Chemoresistance to Pancreatic Cancer Cells by Promoting ROS Detoxification and miR-155-mediated Suppression of Key Gemcitabine-Metabolising Enzyme, DCK

British Journal of Cancer
Cancer ResearchOncology
2017English

SKP2 Confers Resistance of Pancreatic Cancer Cells Towards TRAIL-induced Apoptosis

International Journal of Oncology
Cancer ResearchOncology
2010English

3,3'-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer

Cancer Research
Cancer ResearchOncology
2009English

Resveratrol Inhibits Hypoxia-Driven ROS-induced Invasive and Migratory Ability of Pancreatic Cancer Cells via Suppression of the Hedgehog Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2015English

Cancer Stem Cells in Pancreatic Cancer

Cancers
Cancer ResearchOncology
2010English

ROS/KRAS/AMPK Signaling Determines Gemcitabine-Induced Pancreatic Cancer Stem-Like Cell Property in Vitro

Oncotarget
Oncology
2019English

Targeting Pancreatic Cancer Stem Cells

Journal of Cancer Sciences
2015English

MST1 Suppresses Pancreatic Cancer Progression via ROS Induced Pyroptosis

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Sophoridine Induces Apoptosis and S Phase Arrest via ROS-dependent JNK and ERK Activation in Human Pancreatic Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy